Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Myelodysplastic Syndromes 3Leukemia, Myeloid, Acute 3Glioblastoma 3Brain Neoplasms 3Glioma 2Thyroid Neoplasms 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Neurologic Manifestations 1Neoplasms, Neuroepithelial 1Neoplasm Metastasis 1Lymphoma 1Leukemia 1Head and Neck Neoplasms 1HTLV-I Infections 1Gliosarcoma 1Diffuse Intrinsic Pontine Glioma 1Breast Neoplasms 1Astrocytoma 1

Interventions

Nivolumab 2peginterferon alfa-2b 1Zidovudine 1Valproic Acid 1Pharmacogenomic Testing 1Interferon alpha-2 1Daclizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × HTLV-I Infections × Valproic Acid × Clear all
NCT00854581 2018-04-17

Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma

University of Miami

Phase 4 Terminated
13 enrolled 15 charts
LymphoidOther hematologic neoplasmOther neoplasm

Lymphoma, Precancerous Conditions, HTLV-I Infections, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡